Prof. Eradiri Becomes Fellow of Royal Pharmaceutical Society



Prof. Eradiri Becomes Fellow of Royal Pharmaceutical Society
L-R: Pharm. (Dr) Lambert Eradiri (father); Prof. Claire Anderson, president, Royal Pharmaceutical Society and Prof. Oweikumo Eradiri, at the Fellowship Award ceremony in London.

Professor Oweikumo Eradiri, has received the Fellowship of the Royal Pharmaceutical Society, the highest honour for distinction in the Pharmacy profession.

The Fellowship Award ceremony, held at the Royal Pharmaceutical Society Conference in London on Friday, 11 November, 2022.

Eradiri is a professor of Clinical Pharmacy and Pharmacy practice, with special interests in clinical pharmaceutics, pharmaceutical technology, quality assurance, and medication safety.

His research profile spans the bench-to-bedside spectrum, with involvement in drug development, pharmacy manufacturing, clinical trials, and medication safety practices. His affiliations include Cambridge University, University of East Anglia, and Niger Delta University. Until 2022, he was Chief Pharmacist of East Suffolk and North Essex NHS Foundation Trust, and Vice-Chair of her Research Governance Group. He was also Chair of the Pharmacy Workforce Collaborative Group for the Suffolk and North East Essex Integrated Care System.

Merck announces 2016 winners, calls for applications for 2017 Hypertension Award

He is a Fellow of the Faculty of the Royal Pharmaceutical Society (RPS), with expert practice in Medication Safety (FFRPS, 2014). A number of his simple and practical Medication Safety solutions have been adopted internationally. He is also a Fellow of the Royal Society for Public Health (FRSPH, 2009).

Professor Eradiri is a member of the RPS Hospital Expert Advisory Group and Health Education England’s Global Pharmacy and Medicines Optimisation Group, informing UK Government policy on medicines. He currently represents the RPS on the National Health Service (NHS) England Group revising the UK Guidance for the Aseptic Preparation of Medicines. In addition, he is a member of the World Health Organisation’s Patient Safety and Medication Safety Networks.

Lagos Records 3 New Suspected Coronavirus Cases, Patients in Isolation- Abayomi

At the International Pharmaceutical Federation (FIP) Pharmacy World Congress in Abu Dhabi (2019), he facilitated the signing of a Memorandum of Understanding between the Royal Pharmaceutical Society and the Pharmaceutical Society of Nigeria, for mutual professional development of members.

Until 2020, Professor Eradiri was the Advocacy Lead and Advocacy Advisor for the United Nations Educational, Scientific and Cultural Organisation (UNESCO) – UNITWIN – FIP Network for Global Pharmacy Education Development (GPhED).

Professor Eradiri received the Patient Safety Prize at the UK NHS Innovation Awards (2010), and the NHS Leadership Academy Award in Executive Healthcare Leadership (in partnership with Harvard University, 2017). In May 2021, he was awarded Fellowship of the RPS (FRPharmS), one of the highest honours the RPS bestows upon its members, for distinction in the Pharmacy profession.


Please enter your comment!
Please enter your name here